Minerva Neurosciences Files 2024 Annual Report Amendment
Ticker: NERV · Form: 10-K/A · Filed: Apr 21, 2025 · CIK: 1598646
Sentiment: neutral
Topics: amendment, annual-report, pharmaceutical
TL;DR
Minerva Neurosciences amended its 2024 10-K. Check for updates.
AI Summary
Minerva Neurosciences, Inc. filed an amendment (10-K/A) on April 21, 2025, for its fiscal year ended December 31, 2024. The company, incorporated in Delaware and headquartered in Waltham, MA, is in the pharmaceutical preparations industry. This amendment likely provides updated or corrected information regarding its annual report.
Why It Matters
This filing provides updated financial and operational details for Minerva Neurosciences, Inc. for the 2024 fiscal year, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Minerva Neurosciences faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 001-36517 — SEC File Number (Identifies the company's filings with the SEC)
- 26-0784194 — EIN (Employer Identification Number for tax purposes)
Key Players & Entities
- Minerva Neurosciences, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Waltham, MA (location) — Principal executive offices
- 2024-12-31 (date) — Fiscal year end
- 2025-04-21 (date) — Filing date of amendment
FAQ
What specific information is being amended in this 10-K/A filing?
The filing is an amendment to the annual report for the fiscal year ended December 31, 2024. Specific details of the amendments are not provided in the header information but would be detailed within the document itself.
When was the original 10-K filed for the fiscal year ended December 31, 2024?
The filing header indicates the amendment was filed on April 21, 2025, for the fiscal year ended December 31, 2024. The original filing date is not explicitly stated but would precede this amendment.
What is Minerva Neurosciences, Inc.'s primary business?
Minerva Neurosciences, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
Where is Minerva Neurosciences, Inc. headquartered?
The company's principal executive offices are located at 1500 District Avenue, Burlington, MA 01803, with a business phone number of (617) 600-7373.
What is the significance of the '10-K/A' form type?
A '10-K/A' signifies an amendment to a previously filed annual report (10-K), indicating that corrections or additions are being made to the original filing.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 21, 2025 regarding Minerva Neurosciences, Inc. (NERV).